|
C1ORF55 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62614366416847E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.29685151506465E-12 |
| Normal-vs-Stage2 |
4.19729999645568E-08 |
| Normal-vs-Stage3 |
8.50763903770257E-13 |
| Normal-vs-Stage4 |
8.87520001935371E-09 |
| Stage1-vs-Stage2 |
4.701400E-01 |
| Stage1-vs-Stage3 |
1.334570E-01 |
| Stage1-vs-Stage4 |
3.053200E-01 |
| Stage2-vs-Stage3 |
7.292200E-01 |
| Stage2-vs-Stage4 |
8.280200E-01 |
| Stage3-vs-Stage4 |
9.323400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.95239396766556E-14 |
| Normal-vs-AfricanAmerican |
2.156900E-03 |
| Normal-vs-Asian |
1.3129999976158E-08 |
| Caucasian-vs-AfricanAmerican |
1.275360E-01 |
| Caucasian-vs-Asian |
6.030400E-01 |
| AfricanAmerican-vs-Asian |
9.534300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.66989755356894E-11 |
| Normal-vs-Female |
2.09765538272677E-12 |
| Male-vs-Female |
4.102400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.09830033956371E-10 |
| Normal-vs-Age(41-60Yrs) |
5.20139487036886E-13 |
| Normal-vs-Age(61-80Yrs) |
5.72830671785596E-12 |
| Normal-vs-Age(81-100Yrs) |
4.821700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.965150E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.318370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.194600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.970200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.525400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.252200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.317200E-03 |
| Classical-VS-Follicular |
4.073800E-02 |
| Classical-VS-Other |
1.067230E-01 |
| Classical-VS-Normal |
2.8258000051018E-08 |
| Tall-VS-Follicular |
3.680800E-01 |
| Tall-VS-Other |
4.801000E-01 |
| Tall-VS-Normal |
7.84450282509397E-11 |
| Follicular-VS-Other |
3.936600E-01 |
| Follicular-VS-Normal |
1.11620046538974E-10 |
| Other-VS-Normal |
3.763100E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.44089209850063E-15 |
| Normal-vs-N1 |
1.56059998257518E-09 |
| N0-vs-N1 |
6.845000E-01 |
|
|
